TB-403 has been shown to significantly inhibit tumour growth in xenograft tumour models and is thought to act in a pleiotropic manner and with a complementary mechanism to VEGF(R) inhibitors (Fischer et al, 2007; Rizzo et al, 2010). Here, KDR is linked to neoplasm.